# BEYFORTUS
> **BLA761328** · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2023-07-17
## Drug
- **FDA Application Number:** BLA761328
- **Application type:** Biologics License Application
- **Brand name:** BEYFORTUS
- **Generic name:** NIRSEVIMAB
- **Active ingredients:** NIRSEVIMAB-ALIP
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **Manufacturer:** Sanofi Vaccines US Inc.
- **First approval:** 2023-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761328)
---
*MORVS · CC0 1.0*